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Background: Blood platelet levels are being evaluated as predictive and prognostic indicators of the severity of
malaria infections in humans. However, there are few studies on platelets and Plasmodium falciparum malaria
during pregnancy.
Methods: A case–control study was conducted at Gadarif Hospital in Eastern Sudan, an area characterized by
unstable malaria transmission. The aim of the study was to investigate thrombocytopenia in pregnant women with
P. falciparum malaria (cases) and healthy pregnant women (controls).
Results: The median (interquartile) platelet counts were significantly lower in patients with malaria (N = 60) than in
the controls (N = 60), 61, 000 (43,000–85,000) vs. 249,000 (204,000–300,000)/μL, respectively, p< 0.001. However,
there was no significant difference in the platelet counts in patients with severe P. falciparum malaria (N = 12)
compared with those patients with uncomplicated P. falciparum malaria (N = 48), 68, 000 (33,000-88,000)/μL vs. 61,
000 (45,000–85,000)/μL, respectively, p= 0.8. While none of the control group had thrombocytopenia (platelet count
<75, 000/μL), it was found that 6/12 (50%) and 27/48 (56.2%) (p <0.001) of the patients with severe malaria and
uncomplicated malaria had thrombocytopenia, respectively. Pregnant women with P. falciparum malaria, compared
with the pregnant healthy control group, were at higher risk (OR = 10.1, 95% CI = 4.1–25.18; p< 0.001) of
thrombocytopenia. Two patients experienced bleeding, and there was one maternal death due to cerebral malaria
where the patient’s platelet count was only 28,000/μL.
Conclusion: P. falciparum malaria is associated with thrombocytopenia in pregnant women in this setting. More
research is needed.Background
It has been estimated that, each year, 30.3 million Afri-
can women become pregnant in malaria endemic areas
[1]. Pregnant women are more susceptible to malaria
infections than their non-pregnant counterparts [2].
Malaria during pregnancy is associated with poor mater-
nal and fetal outcomes [3]. In Sudan, pregnant women
in the eastern and central regions are susceptible to mal-
aria infection regardless of their age or parity [4,5], and
the disease is one of the leading causes of maternal and
perinatal mortality [6-8].
Malaria, especially the severe Plasmodium falciparum
form, can cause thrombocytopenia, where there is an* Correspondence: ishagadam@hotmail.com
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reproduction in any medium, provided the orabnormally low number of platelets, and activation of
the coagulation cascade [9,10]. Hence, platelet count is
being evaluated as a predictor and prognostic feature of
malaria infection [11]. However, most research on
thrombocytopenia and malaria is focused on non-
pregnant populations including adults and children with
symptomatic and asymptomatic P. falciparum infections
[12-14]. There are few published data on platelets and
P. falciparum infection during pregnancy [15]. The
current study was conducted at Gadarif Hospital in East-
ern Sudan to investigate thrombocytopenia in pregnant
women infected with P. falciparum malaria parasites. The
area is characterized by unstable malaria transmission;
P. falciparum is the sole malaria species in the area [16],
and the disease is a huge problem among pregnant
women, regardless of their age or parity [17].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Comparing mean(SD) of the basic clinical data













Age, years 26.7 (5.2) 26.0 (5.8) 25.8 (5.4) 0.8
Parity 3.0 (1.6) 3.2 (2.6) 2.4 (2.0) 0.1
Gestational age, weeks 24.7 (6.8) 25 (9.6) 25.8 (10.1) 0.8
Temperature, 0 C 38.5 (0.6) 37.7 (0.7) 37.1 (0.2) 0.3
Haemoglobin, g/dl 9.1 (2.2) 10.2 (1.6) 11.3 (1.3) <0.001
Blood glucose, mg/dl 72.4 (3.0) 74.6 (4.0) — 0.08
Serum bilirubin, mg/dl 2.0 (0.7) 1.8 (0.6) — 0.3
Serum creatinine, mg/dl 1.0 (0.2) 1.0 (0.3) — 0.9
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A case–control study was conducted at the antenatal
clinic in Gadarif Maternity Hospital in Eastern Sudan
during the rainy/post rainy season of June-November
2011. Cases were pregnant women with P. falciparum
malaria confirmed by blood film examination. Controls
were afebrile healthy pregnant women attending for rou-
tine antenatal care without any illness, history, or symp-
toms (headache, dizziness, joint pain, anorexia, nausea,
spontaneous bleeding) suggestive of malaria. In addition,
the controls had parasite negative blood films. After
signing an informed consent form, the obstetrics history
was taken from cases and controls using pre-test ques-
tionnaires. Pregnant women with a hypertensive disorder
of pregnancy (blood pressure of 140/90 mmHg or more,
with or without proteinuria), or pregnant women using
aspirin or heparin were not included in the case or con-
trol groups. The cases were examined thoroughly for
signs of severe P. falciparum infection, and those with
one or more criteria of severe malaria [18] were admit-
ted to the hospital and managed accordingly, as we have
recently described [19]. Women who had not fulfilled
the criteria for severe infection were considered to have
uncomplicated P. falciparum malaria and were treated
with the first-line anti-malarial treatment (artesunate-
sulfadoxine-pyrimethamine) as out-patients according to
the Sudanese National Malaria control policy [20].
Blood films were prepared and stained with Giemsa,
and 100× oil immersion fields were examined. All the
slides were double-checked blindly and only considered
negative if no parasites were detected in 100 fields.
Densities (parasite per μL of whole blood) were then cal-
culated on the basis of the WBC count of the individual
subjects. An average of 500 WBCs were counted for
each subject before parasite densities were estimated.
Thin blood films were used for parasite species
identification.
Two mL of blood were collected from each woman in
the case and control groups. The blood was collected
into ethylenediaminetetraacetic acid anticoagulant
through venipuncture and kept on a roller with constant
mixing. The complete blood count was determined
using a Sysmex automated hematology analyzer in the
lab within one hour of collection. Sysmex accuracy was
determined on a daily basis using manufacturer-
provided samples with known cell counts.
Statistics
Data were entered in computer using SPSS (version 16.0
for Microsoft Windows) and double-checked before ana-
lysis. Continuous variables were checked for normality,
and normally distributed data were described by the
mean (standard deviation) and non-normally distributed
data by the median (interquartile range). Categoricaldata were compared using a Chi-square test or a Fisher's
exact test, as appropriate. Student's t-test and ANOVA
were used to compare the means between two or three
of the groups, respectively. Mann–Whitney and Kruskal-
Wallis H tests were used to analyze medians. A Pearson
correlation test was performed between the platelets
and parasite counts. Univariate and multivariate ana-
lyses were used, with thrombocytopenia (platelet count
<75, 000/μL) as the dependent variable, while age, par-
ity, gestational age, and temperature were the independ-
ent factors. Odds ratios and 95% confidence interval
were calculated, and a P value < 0.05 was considered
significant.
Ethics
The study received ethical clearance from the Research
Board at the Faculty of Medicine, University of Khartoum,
Sudan.
Results
Sixty pregnant women presented with P. falciparum
malaria during the study period, and an equal number of
healthy pregnant women were assigned to the control
group. Out of the 60 P. falciparum-infected women, 12
were diagnosed as severe P. falciparum cases that exhib-
ited various clinical manifestations, including, severe
anemia (3), hypotension (9), jaundice (3), cerebral mal-
aria (1), hyperparasitemia (5), bleeding (2) and more
than one criteria (7).
While there were no significant differences in the
mean values (SD) for the age, parity, gestational age,
temperature, or the biochemical tests between the severe
malaria, uncomplicated malaria and the control groups,
the hemoglobin values were significantly lower in
patients with severe malaria (Table 1). The parasite
count ranged from 5400 to 148350 ring-form parasites/
μL with a geometric mean of 9225.7 rings/μL. None of
Table 2 Comparison of n (%) of women with platelet













<50 5 (41.7) 17 (35.4) 0 (0.0) <0.001
50-74 1 (8.3) 10 (20.8) 0 (0.0) 0.002
75-99 5 (41.7) 15 (31.3) 1 (1.7) <0.001
100-149 1 (8.3) 3 (6.3) 1 (1.7) 0.08
≥150 0 (0.0) 3 (6.3) 58 (96.7) <0.001
Table 3 Risk factors for thrombocytopenia using
univariate and multivariate analyses
Univariate analysis Multivariate analysis
The variable OR 95 % CI P OR 95 % CI P
Age 0.9 0.9–1.0 0.6 1.0 0.9–1.1 0.9
Primigravidae 0.9 0.8–1.1 0.6 0.8 0.6–1.0 0.3
Gestational age 1.0 0.9–1.0 0.9 1.0 0.9–1.0 0.6
Temperature 0.9 0.8–1.0 0.5 0.9 0.7–1.1 0.4
Haemoglobin 1.9 0.8–4.2 0.1 1.0 0.7–1.3 0.8
Malaria 8.5 3.6–20.8 <0.001 10.1 4.1–25.18 <0.001
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Two patients presented with nasal bleeding and bleeding
of the gums.
While none of the controls had thrombocytopenia, it
was found that 6/12 (50%) and 27/48 (56.2%), p< 0.001, of
the patients with severe P. falciparum malaria and uncom-
plicated P. falciparum malaria had thrombocytopenia, re-
spectively (Table 2).
In patients with P. falciparum malaria, the platelet
count ranged from 17,000 to 311,000/μL. The median
(interquartile range) of the platelets was significantly
lower in patients with malaria (both severe and uncom-
plicated P. falciparum malaria) than in the controls,
61,000 (43,000–85,000) vs. 249,000 (204,000–300,000)
(controls), p < 0.001. However, there was no significant
difference in the median (interquartile range) of the pla-
telets in patients with severe malaria compared with
those with uncomplicated P. falciparum malaria, 68,000
(33,000–88,000) vs. 61,000 (45,000–85,000), respectively,
p= 0.8, Figure 1.Figure 1 Comparing platelets count between the patients with P. falcThe univariate and multivariate analyses found that
malaria was the only risk factor for thrombocytopenia
(odds ratio = 10.1, 95% CI = 4.1–25.18; p < 0.001)
(Table 3). There was no significant correlation between
the platelet levels and parasite counts (r= 0.124; P = 0.3).
One patient died during resuscitation, after presenting
with cerebral malaria and minor bleeding from the
gums. This patient’s hemoglobin and platelet counts
were 5 g/dl and 18, 000, respectively.
Discussion
To the best of our knowledge, this is the first published
data on thrombocytopenia in pregnant women infected
with P. falciparum malaria in Africa. The main findings
of the current study were that the platelet counts in
pregnant women with P. falciparum malaria were sig-
nificantly lower than in the controls, and there was no
difference in the platelet counts in women with severe
P. falciparum malaria vs. in the women with uncompli-
cated malaria. One noteworthy finding was that preg-
nant women with malaria had a 10 times higher risk ofiparum malaria and controls.
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P. falciparum malaria infections, there was no significant
correlation between parasite and platelet counts. Re-
cently, Tan et al. observed that pregnant women living at
the Thai-Burmese border were more susceptible to
thrombocytopenia (platelet counts <150,000/μL) than
their non-pregnant counterparts; the median platelet
counts 134,000 (11,000–690,000) in this study were sig-
nificantly lower in pregnant women with P. falciparum
malaria and Plasmodium vivax malaria, with the first
malaria episode increasing the risk of thrombocytopenia
[15]. Interestingly, various definitions of platelet density
(per μL) have been used to define thrombocytopenia
in pregnant women, i.e. 75,000/μL, 115,000/μL and
150,000/μL, and of course, pregnancy itself can lead
to thrombocytopenia [21-24]
In the current study, no correlation was found between
the blood-stage parasite numbers and the platelet counts.
This is in accordance with a previous observation, where
it was shown that the pattern of thrombocytopenia and
parasitemia did not have a linear relationship among
malaria-infected Nigerian children [14]. However, among
Papuan adults, platelet counts were negatively corre-
lated with the level P. falciparum parasitemia [12].
Thrombocytopenia in malaria probably occurs through
peripheral destruction, sequestration or excessive re-
moval of the platelets by the spleen, as well as platelet
consumption by the process of disseminated intravascu-
lar coagulation [25-28]. Platelets have been reported to
enhance clumping of P. falciparum-infected erythrocytes,
and this process might lead to pseudo thrombocytopenia
[29]. In endemic areas, malaria patients have high levels of
specific antibodies (IgG) which bind to platelet-bound
malaria antigens [30].
In the current study, two patients presented with nasal
bleeding and bleeding of the gums, and one of those
who presented with cerebral malaria died. There were
no episodes of bleeding or maternal death in our recent
study on severe malaria among pregnant women in east-
ern Sudan [19]. Thrombocytopenia and spontaneous
bleeding among pregnant women might cause life threa-
tening antepartum or postpartum hemorrhages. Recent
observations document that women with placental mal-
aria are at higher risk of postpartum hemorrhage [31,32].
The question of malaria-associated hemorrhage in preg-
nancy might be addressed by longitudinal studies aimed at
investigating the role played by platelets in peripheral and
placental malaria.
In the current study, no significant difference was
found in the platelet counts when patients with severe
malaria were compared with those who had uncompli-
cated disease. This might be related to the small sample
size in this study because only 12 patients presented
with severe P. falciparum malaria. Nonetheless, Saravuet al. recently found that non-pregnant adult patients
with severe P. falciparum malaria had a statistically sig-
nificant lower platelet count than patients with uncom-
plicated malaria [33]. One of the limitations of the
current study was the lack of the patients` outcomes in
term of the treatment and the pregnancy outcomes.
Conclusion
P. falciparum malaria is associated with thrombocytopenia
in pregnant women in eastern Sudan. More research is
needed.
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